Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-16.75	-17.24	-15.4
Depreciation & Amortization	0.12	0.1	0.05
Stock-Based Compensation	5.74	2.26	-1.41
Other Adjustments	1.12	0.77	-2.19
Change in Receivables	-1.47	-1.52	-1.16
Changes in Accounts Payable	-	-	-1.36
Changes in Income Taxes Payable	8.78	-	0.49
Changes in Other Operating Activities	0.92	-0.06	1.35
Operating Cash Flow	-1.53	-15.7	-19.62
Capital Expenditures	-0.02	-	-
Purchases of Investments	-	-1	-2.68
Other Investing Activities	-0.05	-0.25	-1.32
Investing Cash Flow	-0.07	-1.25	-4
Issuance of Common Stock	4.65	0.02	-
Net Common Stock Issued (Repurchased)	4.65	0.02	-
Other Financing Activities	-0.14	0.02	-0.06
Financing Cash Flow	4.51	0.04	-0.06
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.37	-0.03	-0.4
Net Cash Flow	2.91	-16.91	-23.67
Free Cash Flow	-1.55	-15.7	-19.62
Free Cash Flow Per Share	-0.07	-0.77	-0.97
Levered Free Cash Flow	-2.06	-17.65	-14.86
Unlevered Free Cash Flow	-10.59	-17.48	-14.05

Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q